Lv41
434 积分 2024-02-05 加入
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial
3小时前
已完结
Onradivir: a novel influenza polymerase inhibitor
3小时前
已完结
POS0399 THE ION CHANNEL TRPV4 PARTICIPATES IN THE CARTILAGE PROTECTION OF IGURATIMOD ON KNEE OSTEOARTHRITIS
1个月前
已完结
Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial
1个月前
已完结
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges
1个月前
已完结
Influenza A(H3N2) Subclade K Virus
2个月前
已完结
Process Development toward the Continuous Manufacturing of Baloxavir Marboxil
3个月前
已完结
First-Generation Process Development for the Synthesis of Baloxavir Marboxil: Early-Stage Development of Synthetic Methods to Prepare Baloxavir Marboxil Intermediates
3个月前
已完结
Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy Chinese participants: a first-in-human phase I clinical study
3个月前
已完结
Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial
3个月前
已完结
皖公网安备34019202002308
